4Jan A, Murphy NF,O'Loughlin C, et al. Profiling B-typenatriuretic peptide in a stable heart failure population: a valuable adjunct to care[J]. Ir J Med Sei,2011,180(9) : 355-362.
5Boilson BA, Raichlin E, Park SJ, et al. Device therapy and cardiac transplantation for end-stage heart failure [J]. Curr Probl Cardiol,2010,35(1) :8-11.
6Takao H, Obata JE,Kodama Y,et al. Adiponectin is re- leased from the heart in patients with heart failure[J]. Int J Cardiol, 2009,132 (2) : 221-226.
7Kobalava ZHD,Villevaltde SV, Isikova KHV. The role of adiponectin in development and progression of cardio- vascular diseases[J]. Kardiologiia, 2009,49 (1) : 51-58.
8Dao Q, Krishnaswamy P, Kazanegra R, et al. Utility of B-type natriuretic peptide (BNP) in the diagnosis of CHF in all urgent care setting[J].J Am Coil Cardiol, 2010,37 (5) : 379-383.
9Wieczorek A,Hernandez-Rboles J,Ewing L,et al.Prediction of outcome of fetal congenital heart disease using a cardiovascular profile score[J] .Ultrasound Obstet Gynecol,2008,31(3):284-288.
10Oggè G,Gaglioti P,Maccanti S,et al.Prenatal screening for Congenital heart disease with four-chamberand outflow-tract views:Amulticenter study[J] .Ultrasound Obstet Gynecol,2006,28(6):779-784.
